
Importing a medicine from another country can involve more than the cost of the medicine and international shipping. Depending on the import method and applicable customs rules, patients may also need to account for customs duty, IGST and other charges.
For patients who need medicines that are not approved or commercially available in India, understanding the possible costs before arranging a shipment can help avoid unexpected expenses and delays.
India provides certain customs duty exemptions for eligible medicines imported for personal use. However, these exemptions are subject to specific conditions. Not every imported medicine automatically qualifies for duty relief.
Important disclaimer: This article provides general information and is not tax, legal or medical advice. Customs treatment depends on the medicine, its classification, import method, applicable notifications and the patient's circumstances. Confirm the applicable duty and exemption eligibility with Customs or a qualified customs professional before shipment.
Customs duty may apply to medicines imported into India for personal use, but certain medicines and eligible imports may qualify for exemptions.
The amount payable depends on several factors:
It is important to distinguish between a general personal import and a medicine that qualifies for a specific exemption.
For official information, refer to the Central Board of Indirect Taxes and Customs (CBIC).
The customs assessment may include different components depending on the import route and applicable notification.
Basic Customs Duty is a tax imposed on imported goods under India's customs tariff framework.
The applicable rate depends on the classification of the imported product and the relevant customs notification. Certain medicines may qualify for full or partial exemption from BCD.
Social Welfare Surcharge is a customs surcharge calculated on the applicable Basic Customs Duty.
For certain personal imports, SWS is calculated at 10% of BCD. The actual amount depends on the applicable customs provisions and exemptions.
IGST may apply to imported goods. For the personal-import calculation published by Mumbai Customs, IGST is calculated at 18% on the CIF value plus applicable BCD and SWS.
The applicable tax treatment should be checked for the specific medicine and import classification.
In addition to government taxes, the shipment may involve service charges from the courier company, postal operator or customs clearance provider.
These may include:
These service charges are separate from customs duty and may vary between providers.
The applicable customs duty depends on the import route and whether the medicine qualifies for an exemption.
From 1 April 2026, the tariff rate on dutiable goods imported for personal use under customs heading 9804 was reduced from 20% to 10% Basic Customs Duty. Social Welfare Surcharge may also apply.
Mumbai Customs publishes a calculation for certain personal imports through postal mode involving a monetary transaction. Its published example uses:
Customs component
Illustrative rate
Basic Customs Duty
10%
Social Welfare Surcharge
10% of BCD
IGST
18% on the applicable value and duty components
Illustrative combined duty
30.98%
For an illustrative CIF value of ₹100:
This is an example of the personal-import calculation published by Mumbai Customs. It should not be treated as a universal rate for every medicine shipment.
A medicine covered by a specific customs exemption may receive different treatment. The final assessment is determined by Customs under the applicable notification and import procedure.
Refer to the Mumbai Customs Postal Appraising Section for its published duty structure and calculation.
Certain medicines imported for personal use may qualify for customs duty exemptions under specific government notifications.
The Union Budget 2026-27 introduced additional customs duty relief for patients, particularly those undergoing cancer treatment and those living with rare diseases.
The announced measures include:
These measures do not create a blanket exemption for every medicine imported into India.
The applicable notification, medicine, medical condition and documentation must be checked before claiming an exemption.
You can read the Ministry of Finance announcement on customs duty relief in Budget 2026-27.
The 2026 Budget measures include Basic Customs Duty exemption for the following 17 specified medicines:
The exemption is specific to the listed medicines and the applicable notification conditions. It should not be interpreted as an exemption for all medicines used to treat cancer.
The government has also expanded the list of rare diseases covered by the relevant personal-import duty exemption provisions.
The seven additional rare diseases announced in Budget 2026-27 are:
The exemption for eligible rare-disease medicines and FSMP is subject to the applicable notification and supporting documentation.
For the official details, refer to the Government of India's customs duty changes for 2026-27.
The documents required depend on the exemption and import route.
A patient may need to provide supporting records such as:
A prescription alone does not automatically establish eligibility for a customs duty exemption.
The importer should confirm the specific conditions attached to the exemption before the medicine is dispatched.
For more information about personal-use import documentation, read our guide on Form 12A and Form 12B: Documents to Import Medicine to India.
Yes. The import method can affect the customs procedure, documentation and assessment.
Medicines shipped through private international courier companies are subject to the applicable courier import procedures and customs assessment.
The courier company may request identity documents, shipment details, invoices and additional information before clearance.
Customs may also refer a medicine shipment for regulatory review if additional examination or permission is required.
Medicines arriving through international postal services are handled under the applicable postal import and customs procedures.
The shipment may be assessed by the relevant Foreign Post Office or postal appraising section. The importer may be asked to provide supporting documents before the parcel is released.
Medicines carried by a passenger entering India are subject to the applicable baggage and drug import requirements.
Personal baggage rules and separate courier or postal import procedures should not be treated as interchangeable.
The passenger should confirm the applicable requirements before travelling with a medicine.
For official information, refer to the CBIC customs guidance.
If customs duty or other applicable charges are assessed on a shipment, the importer may need to pay them before the consignment is released.
If the shipment is held for additional information, regulatory review or documentation, clearance may take longer.
Possible issues include:
It is better to confirm the import route, documents and possible tax treatment before dispatch rather than trying to resolve these issues after the shipment arrives in India.
Some specified medicines used in the treatment of cancer and rare diseases may qualify for customs duty relief when imported for personal use.
The Union Budget 2026-27 introduced Basic Customs Duty exemptions for 17 specified medicines and added seven rare diseases to the relevant list for personal imports of drugs, medicines and FSMP.
However, not every cancer medicine or rare-disease treatment automatically qualifies.
Patients should verify:
The treating physician remains responsible for the medical decision. Customs exemption eligibility is a separate regulatory and tax matter.
Sowaka Health coordinates access to medicines prescribed by treating physicians that are not approved or commercially available in India, subject to the applicable regulatory pathway.
International medicine access can involve several connected requirements, including sourcing, import documentation, customs clearance and transportation.
Depending on the medicine and applicable pathway, Sowaka Health can coordinate:
Customs duty and tax treatment must be assessed for the specific medicine and shipment. Any applicable exemption should be verified against the current customs notification before the import is arranged.
Sowaka Health does not replace the treating physician or recommend medicines. Its role is to coordinate the access, regulatory and supply-chain process.
Learn more about Sowaka Health.
Before arranging an international medicine shipment, check the following:
Customs duty may apply to medicines imported into India. However, certain medicines imported for personal use may qualify for exemptions or concessions under specific customs notifications.
There is no single rate that applies to every medicine shipment. The applicable duty depends on the medicine's classification, import method, customs notification and eligibility for exemption.
Certain specified cancer medicines may qualify for Basic Customs Duty exemption when imported for personal use and when the applicable conditions are met. The exemption does not automatically apply to every cancer medicine.
A medicine sent by a family member may still be subject to customs assessment and applicable import requirements. The fact that it is sent by a relative does not automatically make it duty-free.
No. A prescription supports the medical purpose of the import but does not automatically provide a customs duty exemption. The applicable notification and its conditions must also be satisfied.
No. Courier handling, clearance, storage and delivery charges are service charges and are separate from government customs duty and taxes.
You can request an indicative estimate using the medicine details, shipment value and import method. However, the final assessment is determined by Customs under the applicable rules and notifications.
The cost of importing a medicine into India depends on more than its overseas purchase price. Customs duty, IGST, possible exemptions, courier charges and documentation requirements can all affect the final amount.
Some medicines imported for personal use may qualify for customs duty relief, including specified medicines used for cancer and rare diseases. However, eligibility must be checked against the applicable customs notification and supporting conditions.
Before arranging an international shipment, confirm the regulatory import route, customs treatment and documentation requirements. This helps patients and families understand the likely costs and reduce avoidable delays.